Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2863162rdf:typepubmed:Citationlld:pubmed
pubmed-article:2863162lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0012984lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2863162lifeskim:mentionsumls-concept:C0301896lld:lifeskim
pubmed-article:2863162pubmed:issue7lld:pubmed
pubmed-article:2863162pubmed:dateCreated1985-10-18lld:pubmed
pubmed-article:2863162pubmed:abstractTextOf 19 murine antihuman Tp32 (T8) monoclonal antibodies tested, only antibody T811 showed cross-reactivity with canine lymphoid cells. It recognized an antigen expressed on 19%-27% of peripheral blood mononuclear cells (PBMC), 20%-30% of peripheral Thy 1+ T-lymphocytes, 40% of puppy thymocytes, 35%-45% of alloantigen-activated peripheral lymphocytes, and 100% of PBMC from a dog with acute T-cell leukemia. The antigen was not expressed on peripheral Thy 1- cells, bronchoalveolar cells, or null-type acute leukemia cells. The antibody inhibited cell-mediated lympholysis in the absence of complement, while antibody F3-20-7 directed at the canine Thy 1 antigen did not. It was not possible to precipitate a corresponding cell surface antigen on canine cells using standard 125I radioimmunoprecipitation techniques nor did the antibody cause antigenic modulation. Our data suggest that monoclonal antibody T811 reacts with a functional subset of canine T-lymphocytes similar to that of human cells; however, significant differences may exist between the antigens recognized on these cells in the two species.lld:pubmed
pubmed-article:2863162pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:languageenglld:pubmed
pubmed-article:2863162pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:citationSubsetIMlld:pubmed
pubmed-article:2863162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2863162pubmed:statusMEDLINElld:pubmed
pubmed-article:2863162pubmed:monthAuglld:pubmed
pubmed-article:2863162pubmed:issn0301-472Xlld:pubmed
pubmed-article:2863162pubmed:authorpubmed-author:StorbRRlld:pubmed
pubmed-article:2863162pubmed:authorpubmed-author:SvábZZlld:pubmed
pubmed-article:2863162pubmed:authorpubmed-author:DeegH JHJlld:pubmed
pubmed-article:2863162pubmed:authorpubmed-author:RieberPPlld:pubmed
pubmed-article:2863162pubmed:issnTypePrintlld:pubmed
pubmed-article:2863162pubmed:volume13lld:pubmed
pubmed-article:2863162pubmed:ownerNLMlld:pubmed
pubmed-article:2863162pubmed:authorsCompleteYlld:pubmed
pubmed-article:2863162pubmed:pagination641-6lld:pubmed
pubmed-article:2863162pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:meshHeadingpubmed-meshheading:2863162-...lld:pubmed
pubmed-article:2863162pubmed:year1985lld:pubmed
pubmed-article:2863162pubmed:articleTitleMonoclonal antibody to human cytotoxic-suppressor T-lymphocytes cross-reacts with canine lymphocytes and inhibits cell-mediated lympholysis of canine cells.lld:pubmed
pubmed-article:2863162pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2863162pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2863162pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2863162pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed